Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 May 18:16:3101-3108.
doi: 10.2147/IDR.S409701. eCollection 2023.

A Rare Strain Actinomadura geliboluensis Was First Isolated from the Bronchoalveolar Lavage Fluid of a Patient with Pneumonia

Yefu Yu #  1 , Guier Yang #  2 , Yanan Wang  1 , Faxiang Jin  1 , Huiyu Wang  1 , Zhongqiang Yu  3 , Lanqing Li  4 , Xiangcheng Li  4 , Junshun Gao  4 , Wenfang Xu  1
Affiliations
Case Reports

A Rare Strain Actinomadura geliboluensis Was First Isolated from the Bronchoalveolar Lavage Fluid of a Patient with Pneumonia

Yefu Yu et al. Infect Drug Resist. .

Abstract

Background: Actinomadura geliboluensis was first isolated in 2012 in Gelibolu, Canakkale, Turkey, and has not been reported to be isolated from humans until now. We have isolated it from the bronchoalveolar lavage fluid (BLF) of a patient with pneumonia and found its drug resistance. It is the first time that Actinomadura geliboluensis has been isolated from humans since its discovery and naming. This case may provide new ideas and methods for the clinical diagnosis and treatment of pulmonary actinomycosis.

Case description: The patient was a 75-year-old male who was hospitalized in a township hospital and failed to improve after penicillin treatment. After admission to our hospital, the patient was treated with piperacillin/tazobactam according to clinical guidelines for 14 days. Actinomadura geliboluensis was isolated from the patient's BLF and was identified by 16S rRNA sequencing. This report shows the biological characteristics and in vitro drug susceptibility testing, as well as the genomics analysis based on next-generation sequencing (NGS). The results demonstrated that Actinomadura geliboluensis was easy to be mistakenly identified as Actinomyces dental caries by using the Merieux ANC identification card. Based on the MIC test, Actinomadura geliboluensis was susceptible to tetracyclines, quinolones and sulfonamides, but resistant to carbapenems, penicillins and cephalosporins. The K-B test results showed Actinomadura geliboluensis was highly sensitive to piperacillin/tazobactam. Genomic analysis based on NGS showed that the Actinomadura geliboluensis belongs to Planobispora rosea EF-Tu mutants conferring resistance to inhibitor GE2270A, AAC(3)-VIIa, vanRO, chrB, and mexY.

Conclusion: Actinomycetes is generally sensitive to Penicillin but Actinomadura geliboluensis is not. In vitro drug susceptibility test is needed to support individualized drug use to avoid delay in the disease.

Keywords: Actinomadura geliboluensis; antibiotic resistance; genomics; next generation sequencing; pulmonary actinomycosis.

PubMed Disclaimer

Conflict of interest statement

Yefu Yu and Guier Yang contributed equally to this work and should be considered co-first authors. All authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Chest CT image. The township hospital chest CT (A) lung window and (B) longitudinal window shows the left lower lung showed a mass of high-density shadow with vague edge, adjacent to the pleural retraction, and slightly dilated bronchioles in it. The admission chest CT (C) lung window and (D) longitudinal window shows the left lower lung showed a mass of high-density shadow with vague edge, adjacent to the pleural retraction, and slightly dilated bronchioles in it. The discharged chest CT (E) lung window and (F) longitudinal window shows the left lower lung showed stripped-like, patchy high-density shadow with clear boundary, adjacent to the pleural stretch, slightly dilated bronchioles, and more anterior absorption of the lesion.
Figure 2
Figure 2
(A) Colony morphology of Actinomadura geliboluensis after 3 days of culture on Columbia blood plate medium (ultra-micrograph with 4× magnification); (B) weak acid-fast staining (with 2000× magnification) of Actinomadura geliboluensis colonies after slide blotting; (C) Gram staining (with 1000× magnification) of growth in liquid medium of Actinomadura geliboluensis.
Figure 3
Figure 3
Protein fingerprints detected by MALDI TOF.
Figure 4
Figure 4
The timeline shows the entire diagnosis and treatment process of this case.
See this image and copyright information in PMC

References

    1. Izri A, Aljundi M, Billard-Pomares T, et al. Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report. BMC Infect Dis. 2020;20:829. doi:10.1186/s12879-020-05552-z - DOI - PMC - PubMed
    1. Sazak A, Camas M, Spröer C, Klenk HP, Sahin N. Actinomadura geliboluensis sp. nov., isolated from soil. Int J Syst Evol Microbiol. 2012;62:2011–2017. doi:10.1099/ijs.0.036145-0 - DOI - PubMed
    1. Bonifaz A, Tirado Sánchez A, Vázquez González D, Fierro Arias L, Araiza J, González GM. Actinomycetoma by Actinomadura madurae. Clinical and therapeutic characteristics of 18 cases with two treatment modalities. J Dermatol Treat. 2020;33:954–958. doi:10.1080/09546634.2020.1793887 - DOI - PubMed
    1. Bonifaz A, Tirado-Sánchez A, Vazquez-Gonzalez D, Araiza J, Hernández-Castro R. Actinomycetoma by actinomadura madurae: clinical characteristics and treatment of 47 cases. Indian Dermatol Online J. 2021;12:285–289. doi:10.4103/idoj.IDOJ_474_20 - DOI - PMC - PubMed
    1. Ara I, Matsumoto A, Bakir MA, Kudo T, Ōmura S, Takahashi Y. Actinomadura bangladeshensis sp. nov. and Actinomadura chokoriensis sp. nov. Int J Syst Evol Microbiol. 2008;58(7):1653–1659. doi:10.1099/ijs.0.65533-0 - DOI - PubMed

Publication types